129101-54-8

API

C18H28N2O8

400.42

ENA 713, Rivastigmine hydrogen tartrate, Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)Carbamic acid, ethylmethyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (9CI), Rivastigmine hydrogentartrate,Rivastigmine Tartrate, Carbamic acid, ethylmethyl-, 3-[1-(dimethylamino)ethyl]phenyl ester, (S)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1), rivastigmine bitartrate, SDZ-ENA 713, 3-[(1S)-1-(Dimethylamino)ethyl]phenyl ethyl(methyl)carbamate hydrogen (2R,3R)-2,3-dihydroxybutanedioate, Rivastigmine tartrate

• Pharmaceuticals
• Polymers

• APIs

• 1) Certificate of Analysis (COA)
• 2) Material Safety Data Sheet (MSDS) available along with product